Literature DB >> 14507994

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

Laëtitia K Linares1, Arnd Hengstermann, Aaron Ciechanover, Stefan Müller, Martin Scheffner.   

Abstract

The RING finger proteins HdmX and Hdm2 share significant structural and functional similarity. Hdm2 is a member of the RING finger family of ubiquitin-protein ligases E3 and targets the tumor suppressor protein p53 for degradation. Although HdmX also binds to p53, HdmX does not induce p53 degradation. Moreover, HdmX has been reported to interfere with p53 degradation in overexpression experiments. To obtain insight into the mechanism by which HdmX interferes with p53 degradation, we studied the effect of HdmX on the E3 activity of Hdm2 in vitro. Surprisingly, this revealed that HdmX stimulates Hdm2-mediated ubiquitination of p53 and that HdmX facilitates ubiquitination of Hdm2 and vice versa. In addition, down-regulation of HdmX expression within cells results in the accumulation of both p53 and Hdm2. Because HdmX alone does not have appreciable E3 activity, these data indicate that HdmX acts as a stimulator, rather than as an inhibitor, of the E3 activity of Hdm2 and that, at least under certain conditions, HdmX is actively involved in the degradation of both p53 and Hdm2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507994      PMCID: PMC218704          DOI: 10.1073/pnas.2030930100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

3.  Recognition of the polyubiquitin proteolytic signal.

Authors:  J S Thrower; L Hoffman; M Rechsteiner; C M Pickart
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

4.  MdmX protects p53 from Mdm2-mediated degradation.

Authors:  M W Jackson; S J Berberich
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  MDM2 interacts with MDMX through their RING finger domains.

Authors:  S Tanimura; S Ohtsuka; K Mitsui; K Shirouzu; A Yoshimura; M Ohtsubo
Journal:  FEBS Lett       Date:  1999-03-19       Impact factor: 4.124

Review 6.  Ubiquitin in chains.

Authors:  C M Pickart
Journal:  Trends Biochem Sci       Date:  2000-11       Impact factor: 13.807

7.  Hdmx stabilizes Mdm2 and p53.

Authors:  R Stad; Y F Ramos; N Little; S Grivell; J Attema; A J van Der Eb; A G Jochemsen
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

8.  Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation.

Authors:  A Hengstermann; N J Whitaker; D Zimmer; H Zentgraf; M Scheffner
Journal:  Oncogene       Date:  1998-12-03       Impact factor: 9.867

9.  Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain.

Authors:  J Spence; R R Gali; G Dittmar; F Sherman; M Karin; D Finley
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

10.  Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.

Authors:  R Honda; H Yasuda
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

View more
  159 in total

1.  Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition.

Authors:  Michael M Madden; Avinash Muppidi; Zhenyu Li; Xiaolong Li; Jiandong Chen; Qing Lin
Journal:  Bioorg Med Chem Lett       Date:  2011-01-07       Impact factor: 2.823

Review 2.  Advances in pediatric rhabdomyosarcoma characterization and disease model development.

Authors:  D O'Brien; A G Jacob; S J Qualman; D S Chandler
Journal:  Histol Histopathol       Date:  2012-01       Impact factor: 2.303

3.  Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Authors:  Pavlina Dolezelova; Katerina Cetkovska; Karen H Vousden; Stjepan Uldrijan
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

4.  Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.

Authors:  Saravanakumar Iyappan; Hans-Peter Wollscheid; Alejandro Rojas-Fernandez; Andreas Marquardt; Hao-Cheng Tang; Rajesh K Singh; Martin Scheffner
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

5.  Regulation of LIM-domain-binding 1 protein expression by ubiquitination of Lys134.

Authors:  Paul W Howard; Shall F Jue; David G Ransom; Richard A Maurer
Journal:  Biochem J       Date:  2010-07-01       Impact factor: 3.857

6.  Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.

Authors:  Jing Nie; Ping Xie; Lin Liu; Guichun Xing; Zhijie Chang; Yuxin Yin; Chunyan Tian; Fuchu He; Lingqiang Zhang
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

7.  A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.

Authors:  Hongbo Wang; Xujun Ma; Shumei Ren; John K Buolamwini; Chunhong Yan
Journal:  Mol Cancer Ther       Date:  2010-11-12       Impact factor: 6.261

8.  Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.

Authors:  X Zhang; W Wang; H Wang; M-H Wang; W Xu; R Zhang
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

Review 9.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

10.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.